Cancer immunotherapy in patients with preexisting rheumatologic disease: the Mayo Clinic experience

ConclusionTo our knowledge, this represents the largest single‐center cohort of patients with rheumatologic diseases who were exposed to modern cancer immunotherapy. Only a minority of these patients experienced a flare of their preexisting rheumatologic disease or any other IRAE.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - January 1, 2018 Category: Rheumatology Authors: Michael D. Richter, Olga Pinkston, Lisa A. Kottschade, Heidi D. Finnes, Svetomir N. Markovic, Uma Thanarajasingam Tags: Brief Report Source Type: research